The production, biological characterization, chemical characterization and structure of MSD-819 (6-chloro-2-quinoxalinecarboxylic acid 1, 4-dioxide) have been reported elsewhere2>3).
The preparation and testing of seven derivatives of the antibiotic are reported in this paper.
Esters Since MSD-819 undergoes decarboxylation in acid solution, esterification with acid catalysts is not practical. The methyl ester (Compound 2) was prepared by using diazomethane as reported elsewhere2).
Other derivatives were prepared from this compound. The n-butyl ester (Compound 3) was prepared by trans-esterification with an alkaline catalyst.
Amides The carboxamide (Compound 4) and the N-substituted amides were prepared by adding the appropriate base to a methanol solution of the methyl ester. The structural formulas of these derivatives are shown in Fig. 1 .
Materials and Methods
72-Butyl-6-chloro-2-quinoxalinecarboxylate 1, 4-dioxide (Compound 3)
One hundred mg of the methyl ester of MSD-819 was suspended in 100 ml of w-butyl aicohol and 1 ml of tri- Assay Procedures Initial in vitro assays were performed by the disc-plate agar diffusion method using 13 mm discs and Proteus vulgaris MB-838 as the organism. The concentration which gave a 30 mm inhibition zone in the assay was used for determination of antibacterial spectra.
These were determined by the same method except 7 mm discs were used. The results are reported in Table  1 .
In vivo Activity The derivatives, except for the acid hydrazide, were tested in mice and the results are shown in can be made. The methyl ester is at least 20 times as potent as the sodium salt against most of the organisms tested, since a solution of 72ot;h concentration gives zones equal to or greater than those observed with the sodium salt.
The antibacterial spectra of the derivatives are shifted in favor of activity against gram-positive organisms. This is especially true of the esters which give rather large zones against most gram-positive organisms at lower concentration than that used for the sodium salt.
The in vivo results show that only the carboxamide had oral activity against Proteus vulgaris at the levels tested, and the oral to intraperitoneal ratio was about 8 in this one test. A second test showed a ratio of about 14. The other derivatives were not tested at high enough concentrations to state that they were inactive orally at this higher ratio.
The sodium salt, however, in one test, was not active orally at a level more than 70 times the effective intraperitoneal dose for Salmonella schottmuelleri3). Since the butyl ester, the N-hydroxyamide and the N-(hydroxyethyl)-amide were less effective than the other compounds by the intraperitoneal route, they were not tested orally nor were they tested at high enough levels to detect toxicity.
